正在加载视频...

视频加载失败

加载此视频时出现问题。这可能是由于临时网络问题，或视频可能不可用。

𝐀𝐈 𝐍𝐞𝐰𝐬: Bay Area based Medra, which is building a robotics platform that is capable of doing fully automated lab work for drug discovery and then analyzing and optimizing it, announced a $52M series A today. Full video:

BiotechTV

10,745 subscribers

15,086 次观看 • 10 个月前 •via X (Twitter)

Anya Rossi• Live Now

Private livecam show

0 条评论

暂无评论

原始帖子的评论将显示在这里

相关视频

𝐂𝐨𝐦𝐩𝐚𝐧𝐲 𝐍𝐞𝐰𝐬: After switching to a new GalNAc-LNP delivery vehicle a year ago, @VerveTx today announced the initial safety and efficacy data from its VERVE-102 PCSK9 based editor. Co-Founder & CEO Sek Kathiresan MD covers the data. $VERV Full video:

𝐂𝐨𝐦𝐩𝐚𝐧𝐲 𝐍𝐞𝐰𝐬: After switching to a new GalNAc-LNP delivery vehicle a year ago, @VerveTx today announced the initial safety and efficacy data from its VERVE-102 PCSK9 based editor. Co-Founder & CEO Sek Kathiresan MD covers the data. $VERV Full video:

BiotechTV

22,484 次观看 • 1 年前

𝐂𝐨𝐦𝐩𝐚𝐧𝐲 𝐍𝐞𝐰𝐬: With three approved products and filings for more over the near term, Axsome Therapeutics's CEO describes the scale and reach this company is building in the CNS space. $AXSM Full video:

𝐂𝐨𝐦𝐩𝐚𝐧𝐲 𝐍𝐞𝐰𝐬: With three approved products and filings for more over the near term, Axsome Therapeutics's CEO describes the scale and reach this company is building in the CNS space. $AXSM Full video:

BiotechTV

20,956 次观看 • 1 年前

One of the most exciting (and challenging) applications of physical AI is thinking about how it can accelerate scientific discovery. Imagine a robot that can pipette, handle stem cells, operate existing lab machinery, 24/7 - a physical AI scientist. This is what the new episode of Greylock Partners Change Agents is all about, featuring Michelle Lee, founder and CEO of Medra. We talk about building an AI-powered lab, how accelerating physical AI lab experimentation is the key to unlocking drug development, and how Medra is automating experimentation today inside pharma companies. 00:00 Teaser 00:56 Medra’s founding mission 04:17 Hypotheses are not enough 13:27 Medra’s differentiation 20:22 The experimentation bottleneck 27:06 Refining the agent harness 29:05 The role of the physical lab 33:23 Managing context across different customers 34:59 Working with models 40:26 Towards personalized medicine and drug discovery 43:15 AWS for life sciences Thank you for joining Michelle Lee

One of the most exciting (and challenging) applications of physical AI is thinking about how it can accelerate scientific discovery. Imagine a robot that can pipette, handle stem cells, operate existing lab machinery, 24/7 - a physical AI scientist. This is what the new episode of Greylock Partners Change Agents is all about, featuring Michelle Lee, founder and CEO of Medra. We talk about building an AI-powered lab, how accelerating physical AI lab experimentation is the key to unlocking drug development, and how Medra is automating experimentation today inside pharma companies. 00:00 Teaser 00:56 Medra’s founding mission 04:17 Hypotheses are not enough 13:27 Medra’s differentiation 20:22 The experimentation bottleneck 27:06 Refining the agent harness 29:05 The role of the physical lab 33:23 Managing context across different customers 34:59 Working with models 40:26 Towards personalized medicine and drug discovery 43:15 AWS for life sciences Thank you for joining Michelle Lee

Corinne Marie Riley

40,409 次观看 • 1 个月前

𝐀𝐈 𝐍𝐞𝐰𝐬: Why does healthcare productivity barely move, even as technology improves? A new JAMA commentary from former FDA commissioner Scott Gottlieb, MD 🇺🇸 argues that AI could finally change that if regulation and reimbursement catch up. Article link:

𝐀𝐈 𝐍𝐞𝐰𝐬: Why does healthcare productivity barely move, even as technology improves? A new JAMA commentary from former FDA commissioner Scott Gottlieb, MD 🇺🇸 argues that AI could finally change that if regulation and reimbursement catch up. Article link:

BiotechTV

13,800 次观看 • 10 个月前

We raised a $40M Series A to build the automated lab for agentic biology. Last week, we shared the work we did with Paul Jankura: Claude designed proteins, sent them to our automated wet lab, and got real experimental data back. We believe this is where biology is going: AI agents designing experiments, running them in automated wet labs, learning from the results and iterating. But AI can only move as fast as the experiments behind it. To use the potential of AI to cure all diseases, we need to build high-throughput wet lab infrastructure: a “biological gigafactory”. That’s exactly what we’re doing at Adaptyv. Over the past year we’ve grown our lab throughput by over 5x and onboarded more than 100 customers, ranging from bio AI labs like Chai Discovery and Boltz to pharmas like Roche and Novo Nordisk to dozens and dozens of new startups that use AI to radically speed up drug discovery.

We raised a $40M Series A to build the automated lab for agentic biology. Last week, we shared the work we did with Paul Jankura: Claude designed proteins, sent them to our automated wet lab, and got real experimental data back. We believe this is where biology is going: AI agents designing experiments, running them in automated wet labs, learning from the results and iterating. But AI can only move as fast as the experiments behind it. To use the potential of AI to cure all diseases, we need to build high-throughput wet lab infrastructure: a “biological gigafactory”. That’s exactly what we’re doing at Adaptyv. Over the past year we’ve grown our lab throughput by over 5x and onboarded more than 100 customers, ranging from bio AI labs like Chai Discovery and Boltz to pharmas like Roche and Novo Nordisk to dozens and dozens of new startups that use AI to radically speed up drug discovery.

Adaptyv Bio

183,311 次观看 • 1 个月前

🚨IT IS A MATCH🚨 Just in, the glove that detectives found and sent to a lab IS A MATCH for the glove that the kidnapper was wearing in the video. THIS IS A HUGE DISCOVERY!

🚨IT IS A MATCH🚨 Just in, the glove that detectives found and sent to a lab IS A MATCH for the glove that the kidnapper was wearing in the video. THIS IS A HUGE DISCOVERY!

Ashley

307,284 次观看 • 7 个月前

𝐁𝐫𝐞𝐚𝐤𝐢𝐧𝐠 𝐌&𝐀 𝐍𝐞𝐰𝐬: Lilly is acquiring Crossbridgebio, a Texas biotech developing dual payload antibody-drug conjugates, for up to $300M. Co-Founder & CEO Michael Torres tells us.

𝐁𝐫𝐞𝐚𝐤𝐢𝐧𝐠 𝐌&𝐀 𝐍𝐞𝐰𝐬: Lilly is acquiring Crossbridgebio, a Texas biotech developing dual payload antibody-drug conjugates, for up to $300M. Co-Founder & CEO Michael Torres tells us.

BiotechTV

20,285 次观看 • 6 个月前

𝐁𝐈𝐎 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝟐𝟎𝟐𝟓: Ocugen CEO Shankar Musunuri discusses the company's gene therapy platform for eye conditions - one of which is already in a pivotal, with another to start. #BIO2025 $OCGN Full video:

𝐁𝐈𝐎 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝟐𝟎𝟐𝟓: Ocugen CEO Shankar Musunuri discusses the company's gene therapy platform for eye conditions - one of which is already in a pivotal, with another to start. #BIO2025 $OCGN Full video:

BiotechTV

13,873 次观看 • 1 年前

𝐂𝐨𝐦𝐩𝐚𝐧𝐲 𝐍𝐞𝐰𝐬: Abivax CEO Marc de Garidel discusses freshly released maintenance part 2 results for obefazimod in UC and describes how he believes it builds on initial data announced earlier this month. $ABVX Watch the full video:

𝐂𝐨𝐦𝐩𝐚𝐧𝐲 𝐍𝐞𝐰𝐬: Abivax CEO Marc de Garidel discusses freshly released maintenance part 2 results for obefazimod in UC and describes how he believes it builds on initial data announced earlier this month. $ABVX Watch the full video:

BiotechTV

22,305 次观看 • 3 个月前

𝐂𝐨𝐦𝐩𝐚𝐧𝐲 𝐍𝐞𝐰𝐬: Renowned scientist and entrepreneur Greg Verdine announced $263M in new funding for his company LifeMine Therapeutics. Participating investors include names like Bezos and Gates. See the full interview:

𝐂𝐨𝐦𝐩𝐚𝐧𝐲 𝐍𝐞𝐰𝐬: Renowned scientist and entrepreneur Greg Verdine announced $263M in new funding for his company LifeMine Therapeutics. Participating investors include names like Bezos and Gates. See the full interview:

BiotechTV

20,584 次观看 • 2 个月前

Lacy announced that he and StableRonaldo are planning on dropping a 'Off-stream' series where they have to work a variety of 9-5 jobs and it might even become a series on a different platform👀🔥 - Working at a Restaurant for a day - Working at a Office job for a day - Working Construction for a day

Lacy announced that he and StableRonaldo are planning on dropping a 'Off-stream' series where they have to work a variety of 9-5 jobs and it might even become a series on a different platform👀🔥 - Working at a Restaurant for a day - Working at a Office job for a day - Working Construction for a day

Lacy Updates

24,251 次观看 • 1 个月前

Demis Hassabis just described the exact architecture he is building to cure all human disease and said the breakthrough will not come gradually. It will hit all at once. He is building a full platform to do it. Think of it as a dozen AlphaFold-level models, each one covering a different step in the drug discovery process, all stitched together into a single engine that can be pointed at almost any disease area on earth. AlphaFold solved protein structure. It then folded 200 million proteins in a single year. Hassabis is now building the equivalent of that for every other step like protein interactions, molecular binding, toxicity prediction, drug design, and clinical stratification. Each one its own AlphaFold. All of them connected. He is already testing it on disease profiles in pre-clinical stages right now. Most biotech analysts still model drug discovery timelines in decades. McKinsey published a report estimating AI could reduce discovery timelines by 25 to 50 percent. Hassabis is not describing a 25 percent improvement. He is describing a complete replacement of the process. Do not expect a slow drip of results. Expect nothing for a few years and then a sudden explosion where everything works at once. Demis is running the same play. At a scale that makes AlphaFold look like a warm-up act. (Watch the full interview on YouTube at Two Minute Papers channel)

Demis Hassabis just described the exact architecture he is building to cure all human disease and said the breakthrough will not come gradually. It will hit all at once. He is building a full platform to do it. Think of it as a dozen AlphaFold-level models, each one covering a different step in the drug discovery process, all stitched together into a single engine that can be pointed at almost any disease area on earth. AlphaFold solved protein structure. It then folded 200 million proteins in a single year. Hassabis is now building the equivalent of that for every other step like protein interactions, molecular binding, toxicity prediction, drug design, and clinical stratification. Each one its own AlphaFold. All of them connected. He is already testing it on disease profiles in pre-clinical stages right now. Most biotech analysts still model drug discovery timelines in decades. McKinsey published a report estimating AI could reduce discovery timelines by 25 to 50 percent. Hassabis is not describing a 25 percent improvement. He is describing a complete replacement of the process. Do not expect a slow drip of results. Expect nothing for a few years and then a sudden explosion where everything works at once. Demis is running the same play. At a scale that makes AlphaFold look like a warm-up act. (Watch the full interview on YouTube at Two Minute Papers channel)

Ihtesham Ali

101,601 次观看 • 3 个月前

"A lab leak could be that someone was out in the wild, maybe looking for different types of viruses in bats, got infected, went into a lab, and was being studied in a lab, and then it came out of the lab. But if that's the definition of a lab leak, Jim, then that still is a natural occurrence."

"A lab leak could be that someone was out in the wild, maybe looking for different types of viruses in bats, got infected, went into a lab, and was being studied in a lab, and then it came out of the lab. But if that's the definition of a lab leak, Jim, then that still is a natural occurrence."

Nicholson Baker

1,842,718 次观看 • 3 年前

$RKLB Rocket Lab Robotics is very exciting! It makes Rocket Lab "one of the few companies in the world capable of delivering Mars missions across the entire spectrum. That's launch, spacecraft, software, and now Mars proven robotics for surface and on orbit operations." More info in the video below 👇

$RKLB Rocket Lab Robotics is very exciting! It makes Rocket Lab "one of the few companies in the world capable of delivering Mars missions across the entire spectrum. That's launch, spacecraft, software, and now Mars proven robotics for surface and on orbit operations." More info in the video below 👇

ValueOverPrice

13,475 次观看 • 3 个月前

Most people in the Bay Area are familiar with Georgia Tech as the HPC Garage parallel computing research lab. Not a lot of Bay Area techies know that the state is also home to the University of Georgia which apparently is good at football.

Most people in the Bay Area are familiar with Georgia Tech as the HPC Garage parallel computing research lab. Not a lot of Bay Area techies know that the state is also home to the University of Georgia which apparently is good at football.

SemiAnalysis

28,282 次观看 • 11 个月前

Residents of Pangani have raised concerns over a cracked building in the area that poses a significant danger to both its occupants and neighbors. The building is fully occupied.

Residents of Pangani have raised concerns over a cracked building in the area that poses a significant danger to both its occupants and neighbors. The building is fully occupied.

The Kenyan Vigilante

77,542 次观看 • 6 个月前